Standout Papers

Omalizumab for the Treatment of Chronic Idiopathic or Sp... 2004 2026 2011 2018 688
  1. Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria (2013)
    Marcus Maurer, Karin Rosén et al. New England Journal of Medicine
  2. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1 (2010)
    Marcus Maurer, Karsten Weller et al. Allergy
  3. Macrophage inflammatory protein-1 (2004)
    Marcus Maurer, Esther von Stebut The International Journal of Biochemistry & Cell Biology
  4. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria (2009)
    Torsten Zuberbier, Riccardo Asero et al. Allergy
  5. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy (2013)
    Allen P. Kaplan, Dennis K. Ledford et al. Journal of Allergy and Clinical Immunology
  6. Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study (2014)
    Sarbjit S. Saini, Carsten Bindslev‐Jensen et al. Journal of Investigative Dermatology
  7. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta‐analysis (2019)
    Julia Fricke, G. Avila Valle et al. Allergy
  8. Urticaria (2022)
    Pavel Kolkhir, Ana M. Giménez‐Arnau et al. Nature Reviews Disease Primers
  9. Autoimmune chronic spontaneous urticaria (2022)
    Pavel Kolkhir, Melba Muñoz et al. Journal of Allergy and Clinical Immunology
  10. Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria (2022)
    Marcus Maurer, William Berger et al. Journal of Allergy and Clinical Immunology
  11. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs (2023)
    Pavel Kolkhir, Cezmi A. Akdiş et al. Nature Reviews Drug Discovery
  12. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials (2024)
    Marcus Maurer, Thomas B. Casale et al. Journal of Allergy and Clinical Immunology
  13. Remibrutinib in Chronic Spontaneous Urticaria (2025)
    Martin Metz, Michihiro Hide et al. New England Journal of Medicine

Immediate Impact

14 by Nobel laureates 24 from Science/Nature 74 standout
Sub-graph 1 of 19

Citing Papers

Atopic dermatitis
2025 Standout
Cellular and molecular mechanisms of skin wound healing
2024 Standout
27 intermediate papers

Works of Marcus Maurer being referenced

Mast cells are required for normal healing of skin wounds in mice
2006
Intact hair follicle innervation is not essential for anagen induction and development
1998
and 13 more

Author Peers

Author Last Decade Papers Cites
Marcus Maurer 18042 10606 10699 834 32.3k
Georg Schett 21847 2610 17536 1.1k 57.5k
Lars Klareskog 21624 3641 13668 653 41.5k
Yoshiya Tanaka 14001 3728 9387 1.1k 29.3k
Peter Valent 8482 6397 16304 886 39.5k
Juliet N. Barker 2705 3105 16763 539 30.3k
Gerd R Burmester 15224 3064 8677 589 27.4k
Stephen J. Galli 4840 2467 27221 350 43.5k
C.E.M. Griffiths 5624 603 25889 751 43.5k
Thomas Ruzicka 3180 782 6096 660 25.3k
Thomas A. Luger 3161 866 8150 503 26.9k

All Works

Loading papers...

Rankless by CCL
2026